Vulvar carcinoma: dilemma, debates, and decisions

Area of Science:

• Gynecologic Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Vulvar carcinoma is a rare, aggressive gynecological malignancy primarily affecting elderly females.
• Metastasis to inguinal and pelvic lymph nodes is common, complicating treatment and prognosis.
• Current treatments, including surgery, often lead to significant morbidities and psychosexual issues.

Purpose of the Study:

• To review and discuss treatment options for vulvar carcinoma across different stages.
• To evaluate the evidence for various treatment modalities in managing this rare cancer.
• To address the challenges in treating advanced-stage vulvar cancer, particularly in regions like India.

Main Methods:

• Comprehensive review of published literature and clinical trials on vulvar carcinoma treatment.
• Analysis of treatment outcomes based on disease stage and patient demographics.
• Exploration of multimodality treatment approaches, including surgery, chemotherapy, and radiotherapy.

Main Results:

• Surgery is the primary curative option for early-stage vulvar cancer but is associated with significant morbidities.
• Multimodality treatments are often necessary for advanced stages, but evidence supporting their efficacy is limited.
• Heterogeneous incidence and late-stage presentation are observed in certain regions, impacting treatment strategies.

Conclusions:

• Treatment decisions for vulvar carcinoma must be individualized based on stage, patient factors, and available resources.
• Further research is needed to improve treatment efficacy and reduce morbidity associated with vulvar cancer management.
• Multimodality approaches, while essential for advanced disease, require more robust evidence to guide optimal application.